Name: Medical Digest
Author: Medical Digest

眼科5 件

重要度 3

Innovations in glaucoma treatment: development and testing of a novel self-adjustable implant for effective pressure regulation.

論文発表日: 2026-07-27

Microsystems & nanoengineering

Medical Digest 収録日: 2026-07-29

This study introduces a compact, passive glaucoma implant designed to dynamically modulate hydraulic resistance and maintain intraocular pressure within physiological ranges. The implant effectively regulates pressure, mitigates early hypotony, and adapts to increasing downstream resistance. Ex v...

PubMedで読む

重要度 2

Ocular Response Analyzer versus Goldmann Applanation Tonometry in a Population-based Sample: The Thessaloniki Eye Study.

論文発表日: 2026-07-27

American journal of ophthalmology

Medical Digest 収録日: 2026-07-29

This study compared corneal-compensated intraocular pressure (IOPcc) with Goldmann applanation tonometry (GAT-IOP) in an elderly cohort. Using data from the Thessaloniki Eye Study, it found that IOPcc was on average 2.75 mmHg higher than GAT-IOP. The prevalence of ocular hypertension increased fr...

PubMedで読む

重要度 2

Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study.

論文発表日: 2026-07-27

Ophthalmology and therapy

Medical Digest 収録日: 2026-07-29

この後ろ向きコホート研究は、多民族コホートにおける多発性脈絡膜血管腫症（PCV）に対するファリシマブ治療の12ヶ月間の転帰を評価しました。治療未経験の眼では、視力は+6.8文字（P < 0.01）改善し、CSTは-54 µm（P < 0.01）減少しました。治療経験のある眼では、視力の変化はわずか（+0.27文字、P > 0.05）でしたが、CSTは-40 µm（P < 0.01）減少しました。ファリシマブは、特に治療未経験の眼において臨床的に意味のある視力および解剖学的改善を示しました。これらの知見を検証するためには、適切な民族代表性を持つ前向き研究が必要です。

PubMedで読む

重要度 2

Efficacy and safety at 12 months of PRESERFLO® combined with DuraGen® and morphological evaluation using AS-OCT.

論文発表日: 2026-07-27

Archivos de la Sociedad Espanola de Oftalmologia

Medical Digest 収録日: 2026-07-29

This prospective study evaluated the efficacy and safety of PRESERFLO® implantation combined with 0.04% MMC and DuraGen® in 50 eyes with moderate or severe glaucoma. The mean preoperative intraocular pressure (IOP) was 26.8 ± 7.1 mmHg, which decreased to 13.1 ± 4.5 mmHg, a reduction of 47.9% (p <...

PubMedで読む

重要度 2

Association between Pre-diagnostic Macular Thickness With Risk of Age-related Macular Degeneration.

論文発表日: 2026-07-27

Retina (Philadelphia, Pa.)

Medical Digest 収録日: 2026-07-29

This study involving 40,078 participants from the UK Biobank aimed to determine if specific pre-diagnostic macular thickness patterns are linked to an increased risk of age-related macular degeneration (AMD). Using optical coherence tomography (OCT) imaging, two distinct macular thickness profile...

PubMedで読む

医学研究トレンド

眼科5 件

Innovations in glaucoma treatment: development and testing of a novel self-adjustable implant for effective pressure regulation.

Ocular Response Analyzer versus Goldmann Applanation Tonometry in a Population-based Sample: The Thessaloniki Eye Study.

Real-World Outcomes of Faricimab for Polypoidal Choroidal Vasculopathy in a Multi-ethnic Cohort: A 12-Month Retrospective Study.

Efficacy and safety at 12 months of PRESERFLO® combined with DuraGen® and morphological evaluation using AS-OCT.

Association between Pre-diagnostic Macular Thickness With Risk of Age-related Macular Degeneration.

パーソナライズされた毎日の要約を受け取る